Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to $124000.0.

  • CV Sciences' Share-based Compensation rose 4252.87% to $124000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $478000.0, marking a year-over-year increase of 15561.5%. This contributed to the annual value of $258000.0 for FY2024, which is 1834.86% up from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Share-based Compensation is $124000.0, which was up 4252.87% from $132000.0 recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Share-based Compensation peaked at $912000.0 during Q2 2021, and registered a low of $30000.0 during Q1 2024.
  • Its 5-year average for Share-based Compensation is $266789.5, with a median of $124000.0 in 2025.
  • In the last 5 years, CV Sciences' Share-based Compensation tumbled by 8399.12% in 2022 and then soared by 29333.33% in 2025.
  • Quarter analysis of 5 years shows CV Sciences' Share-based Compensation stood at $835000.0 in 2021, then crashed by 79.64% to $170000.0 in 2022, then crashed by 80.59% to $33000.0 in 2023, then surged by 215.15% to $104000.0 in 2024, then grew by 19.23% to $124000.0 in 2025.
  • Its last three reported values are $124000.0 in Q3 2025, $132000.0 for Q2 2025, and $118000.0 during Q1 2025.